NASDAQ: RZLTRezolute Inc Stock Ownership - Who owns Rezolute?
Insider buying vs selling
Have Rezolute Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Brian Kenneth Roberts | Chief Medical Officer | 2025-06-25 | 2,500 | $4.38 | $10.94kBuy |
| Daron Evans | CFO | 2025-06-24 | 5,000 | $4.05 | $20.25kBuy |
| Nerissa Kreher | Director | 2025-06-13 | 3,076 | $3.25 | $10.00kBuy |
| Youngjin Kim | Director | 2025-06-13 | 1,230,769 | $3.25 | $4.00MBuy |
| Wladimir Hogenhuis | Director | 2025-03-31 | 6,758 | $2.92 | $19.73kBuy |
| Nevan C. Elam | CEO | 2025-03-27 | 12,302 | $2.85 | $35.00kBuy |
| Daron Evans | CFO | 2025-03-26 | 10,000 | $2.88 | $28.80kBuy |
| Daron Evans | CFO | 2025-03-26 | 10,000 | $2.89 | $28.90kBuy |
| Wladimir Hogenhuis | Director | 2025-02-18 | 10,000 | $4.70 | $47.00kBuy |
| Daron Evans | CFO | 2024-12-18 | 10,000 | $4.29 | $42.90kBuy |
RZLT insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when RZLT insiders and whales buy or sell their stock.
RZLT Shareholders
What type of owners hold Rezolute Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Genexine Inc | 106.76% | 91,300,933 | $403.55M | Insider |
| Federated Hermes Inc | 13.19% | 11,279,327 | $49.85M | Institution |
| Youngjin Kim | 10.03% | 8,573,336 | $37.89M | Insider |
| Fmr LLC | 7.61% | 6,507,718 | $28.76M | Institution |
| Handok Inc | 6.95% | 5,942,617 | $26.27M | Insider |
| Vanguard Group Inc | 2.78% | 2,375,378 | $10.50M | Institution |
| Vivo Capital LLC | 2.47% | 2,112,432 | $9.34M | Institution |
| Marshall Wace LLP | 2.16% | 1,845,247 | $8.16M | Institution |
| Blackstone Inc | 2.04% | 1,744,740 | $7.71M | Institution |
| Affinity Asset Advisors LLC | 1.99% | 1,700,000 | $7.51M | Institution |
RZLT vs Biotech Stocks
Rezolute Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.